Compare VTAK & ORIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VTAK | ORIS |
|---|---|---|
| Founded | 2002 | 2014 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Farming/Seeds/Milling |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1M | 3.7M |
| IPO Year | 2018 | 2024 |
| Metric | VTAK | ORIS |
|---|---|---|
| Price | $2.08 | $0.09 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 54.5K | ★ 2.5M |
| Earning Date | 11-13-2025 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.00 |
| Revenue | $730,000.00 | ★ $12,317,000.00 |
| Revenue This Year | $822.86 | N/A |
| Revenue Next Year | $168.42 | N/A |
| P/E Ratio | ★ N/A | $233.06 |
| Revenue Growth | ★ 82.96 | N/A |
| 52 Week Low | $1.49 | $0.07 |
| 52 Week High | $15.68 | $2.85 |
| Indicator | VTAK | ORIS |
|---|---|---|
| Relative Strength Index (RSI) | 42.71 | 30.50 |
| Support Level | $2.00 | $0.07 |
| Resistance Level | $3.06 | $0.11 |
| Average True Range (ATR) | 0.29 | 0.01 |
| MACD | -0.04 | -0.00 |
| Stochastic Oscillator | 12.07 | 34.59 |
Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System), which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.
Oriental Rise Holdings Ltd is an integrated supplier of tea products in China. It is principally engaged in the business of planting, cultivating, processing, and selling processed tea. The company currently produces and sells three categories of products: roughly processed white tea, roughly processed black tea, and refined tea. The company's business operations are vertically integrated, covering cultivation, processing of tea leaves, and the sale of tea products to tea business operators and end-user retail customers. Geographically, the company generates all of its revenue from its business in the People's Republic of China (the PRC).